Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens (Q40703649)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2001
edit
Language Label Description Also known as
English
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens
scientific article published on June 2001

    Statements

    Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens (English)
    van der Burg SH
    Kwappenberg KM
    O'Neill T
    Brandt RM
    Melief CJ
    Hickling JK
    Offringa R
    1 June 2001
    3652-3660

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit